• Family of patient who died after orthopedic surgery wins $35M verdict against hospital
  • Orthopedic surgeon wins $20M verdict against Johnson & Johnson
  • Minnesota orthopedic group hit with $111M negligence verdict
  • Orthopedic patient's death highlights potential dangers of prior authorization
  • Spine surgeon's video hits 1 million views on TikTok
  • Spine surgeon killed in Oklahoma hospital shooting
  • Spine surgeon owes $17M to paralyzed patient
  • Providence to pay $22.7M to settle unnecessary spine surgery allegations
  • Spine surgeon gets jail time for abusing patient during hospital visit
  • 'They're on really thin ice': Why 1 insurer has drawn spine surgeons' ire
  • Connecticut hospital to appeal $12.5M verdict to family of patient who died after orthopedic surgery
  • Orthopedic surgeon must face suit in patient's death
  • Spine surgeon 1 of 9 physician billionaires on Forbes' 2022 list
  • 23 spine device companies to watch in 2022
  • 4 spine technologies that promised more than they delivered
  • Orthopedic surgeon salary vs. average household income in each state
  • Orthopedic surgeon's health system exit steeped in controversy
  • Terminated orthopedic surgeon contracts with another New York hospital
  • Orthopedic surgeon convicted of battery at hospital
  • Billionaire spine surgeon buys $23.9M mansion
  • UArizona neurosurgery chair dies after motorcycle collision
  • Texas spine surgeon sued by State Farm over 'unnecessary' procedures
  • The spine tech surgeons say will explode in the next 5 years
  • Could Medtronic's spine business be the next medtech spinoff?
  • Ex-NFL player gets 5 years in prison for $2.9M healthcare fraud scheme
  • 41 'rising stars' in orthopedics
  • Orthopedic surgeon indicted in $10M telemedicine fraud scheme
  • Neurosurgeon's startup hits $1.2B valuation
  • Orthopedic surgeon fined for operating on wrong knee
  • Lawsuits build against Aetna's spine surgery coverage
  • Good news, bad news for orthopedic surgeons: 6 observations
  • Former spine surgeon owes $13M to 2 women over unnecessary procedures
  • Walmart's latest partnership pushes retailer into spine care
  • Texas spine surgeon's $11M verdict being appealed
  • 10 power players in orthopedics
  • Rothman Orthopaedics to become national brand, but no 'aspirations to go beyond US'
  • Sports medicine physician fired amid misconduct allegations involving patients
  • Orthopedic surgeon allegedly exaggerated patient visits to defraud insurers
  • Top orthopedic hospital in every state: US News
  • Orthopedic surgeon asking for misconduct charges to be dropped
  • How Medtronic is strengthening its spine business
  • $85M settlement reached in spinal cord stimulation lawsuits
  • Medtronic's next-gen predictive spine surgery model cleared
  • ZimVie's pediatric scoliosis device gets coverage by Anthem BCBS
  • Spinal fusion alternative device reaches FDA milestone
  • Orthopedic surgeons critical of Intermountain's supplier switch

    Orthopedic surgeons critical of Intermountain's supplier switch

    Laura Dyrda -  

    Salt Lake City-based Intermountain Healthcare's decision to drop Arthrex for DePuy Synthes products has come under fire, according to a report in The Salt Lake Tribune.

    Arthrex had been the longstanding orthopedic device supplier for Intermountain until January, when the system and its insurance subsidiary signed a new deal with DePuy Synthes estimated to generate $5 million in savings this year. Intermountain orthopedic surgeon Paul Winterton, MD, spoke out against the move, suggesting the decision was driven by payments DePuy Synthes made to colleagues.

    Hugh West, MD, the surgeon who led an internal committee review of orthopedic device supplies, has received $13 million in royalties from DePuy Synthes in the last seven years, according to the federal government. He received royalties for his inventions and does not get paid when the devices are used. The Salt Lake Tribune said nine physicians it interviewed, in addition to Dr. Winterton, reported concerns about Intermountain's decision to switch suppliers, arguing the new supplier's implants are lower quality and surgeons will have a learning curve to implementing the devices, which could affect outcomes.

    "They are willing to compromise patient care over a few pennies," Dr. Winterton told the publication. "It's just absolutely despicable."

    Dr. Winterton and other Intermountain physicians received payments from Arthrex for training, consulting and other services, but not royalties. It is common for orthopedic companies to pay for surgeon training and consulting since the surgeons spend time away from their practices for these activities.

    Intermountain told the publication its decision to switch suppliers was driven by costs and Arthex's proposal didn't meet the system's pricing requirements.

    Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

    Featured Learning Opportunities

    Featured Webinars

    Featured Podcast

    Featured Whitepapers